{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:55:56Z","timestamp":1792119356034,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Chinese National Science Foundation","doi-asserted-by":"publisher","award":["81802394 to Xiao-Hong Pu"],"award-info":[{"award-number":["81802394 to Xiao-Hong Pu"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["021414380408 to Xiao-Hong Pu"],"award-info":[{"award-number":["021414380408 to Xiao-Hong Pu"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.prp.2020.152857","type":"journal-article","created":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T16:26:52Z","timestamp":1581438412000},"page":"152857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["C-MET in intrahepatic cholangiocarcinoma: High-Frequency amplification predicts protein expression and a unique molecular subtype"],"prefix":"10.1016","volume":"216","author":[{"given":"Xiao-Hong","family":"Pu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Shan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2020.152857_bib0005","first-page":"349","article-title":"Modern diagnostic approaches to cholangiocarcinoma","volume":"11","author":"Vasilieva","year":"2012","journal-title":"HBPD INT"},{"key":"10.1016\/j.prp.2020.152857_bib0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1055\/s-0031-1272839","article-title":"Intrahepatic cholangiocarcinoma: new insights in pathology","volume":"31","author":"Sempoux","year":"2011","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.prp.2020.152857_bib0015","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/PPO.0b013e3181a7467d","article-title":"Intrahepatic cholangiocarcinoma: a worthy challenge","volume":"15","author":"Bartlett","year":"2009","journal-title":"Cancer J."},{"key":"10.1016\/j.prp.2020.152857_bib0020","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.suc.2010.04.011","article-title":"Intrahepatic cholangiocarcinoma","volume":"90","author":"Poultsides","year":"2010","journal-title":"Surg. Clin. North Am."},{"key":"10.1016\/j.prp.2020.152857_bib0025","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","article-title":"Cholangiocarcinoma","volume":"383","author":"Razumilava","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.prp.2020.152857_bib0030","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prp.2020.152857_bib0035","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/17474124.2017.1309290","article-title":"Intrahepatic cholangiocarcinoma: current management and emerging therapies","volume":"11","author":"Rahnemai-Azar","year":"2017","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.prp.2020.152857_bib0040","first-page":"437","article-title":"Treatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead-transarterial chemoembolization and systemic chemotherapy","volume":"24","author":"Kuhlmann","year":"2012","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.prp.2020.152857_bib0045","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/MOG.0b013e3283523c7e","article-title":"Genetic profiling of intrahepatic cholangiocarcinoma","volume":"28","author":"Andersen","year":"2012","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.prp.2020.152857_bib0050","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1053\/j.gastro.2013.01.001","article-title":"Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes","volume":"144","author":"Sia","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.prp.2020.152857_bib0055","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/jhbp.155","article-title":"Molecular pathogenesis of intrahepatic cholangiocarcinoma","volume":"22","author":"Andersen","year":"2015","journal-title":"J. Hepatobiliary. Sci."},{"key":"10.1016\/j.prp.2020.152857_bib0060","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1634\/theoncologist.2013-0352","article-title":"New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing","volume":"19","author":"Ross","year":"2014","journal-title":"Oncologist"},{"key":"10.1016\/j.prp.2020.152857_bib0065","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/path.1779","article-title":"Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers","volume":"206","author":"Nakazawa","year":"2005","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2020.152857_bib0070","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/bjc.2011.199","article-title":"Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma","volume":"105","author":"Miyamoto","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2020.152857_bib0075","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrm1261","article-title":"Met, metastasis, motility and more","volume":"4","author":"Birchmeier","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.prp.2020.152857_bib0080","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1158\/1078-0432.CCR-12-2791","article-title":"Targeting the HGF\/c-MET pathway in hepatocellular carcinoma","volume":"19","author":"Goyal","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2020.152857_bib0085","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.7150\/jca.17898","article-title":"The clinical impact of c-MET over-expression in advanced biliary tract Cancer (BTC)","volume":"8","author":"Heo","year":"2017","journal-title":"J. Cancer"},{"key":"10.1016\/j.prp.2020.152857_bib0090","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/1533034615578959","article-title":"Prognostic value of C-met expression in Cholangiocarcinoma","volume":"15","author":"Mao","year":"2016","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.prp.2020.152857_bib0095","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/hep.24450","article-title":"c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma","volume":"54","author":"You","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.prp.2020.152857_bib0100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12943-018-0796-y","article-title":"Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities","volume":"17","author":"Zhang","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2020.152857_bib0105","series-title":"International Agency for Research on Cancer. WHO Classification of Tumours of the Digestive System","author":"Bosman","year":"2010"},{"key":"10.1016\/j.prp.2020.152857_bib0110","series-title":"Cancer Staging Handbook: From the AJCC Cancer Staging Manual","first-page":"247","author":"Edge","year":"2010"},{"key":"10.1016\/j.prp.2020.152857_bib0115","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/00000478-199512000-00007","article-title":"Chronic hepatitis. An update on terminology and reporting","volume":"19","author":"Batts","year":"1995","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2020.152857_bib0120","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","article-title":"Pathogenesis, diagnosis, and management of cholangiocarcinoma","volume":"145","author":"Rizvi","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.prp.2020.152857_bib0125","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/hep.26890","article-title":"Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma","volume":"59","author":"Arai","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.prp.2020.152857_bib0130","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.humpath.2014.03.014","article-title":"Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma","volume":"45","author":"Graham","year":"2014","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2020.152857_bib0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004135","article-title":"Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma","volume":"10","author":"Borad","year":"2014","journal-title":"PLoS Genet."},{"key":"10.1016\/j.prp.2020.152857_bib0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115383","article-title":"Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications","volume":"9","author":"Churi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2020.152857_bib0145","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1245\/s10434-014-3828-x","article-title":"Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets","volume":"21","author":"Zhu","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.prp.2020.152857_bib0150","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1634\/theoncologist.2011-0386","article-title":"Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping","volume":"17","author":"Borger","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.prp.2020.152857_bib0155","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.humpath.2011.12.007","article-title":"Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma","volume":"43","author":"Kipp","year":"2012","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2020.152857_bib0160","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1634\/theoncologist.2015-0210","article-title":"Prognosis and clinicopathologic features of patients with advanced stage isocitrate dehydrogenase (IDH) mutant and IDH wild-type intrahepatic cholangiocarcinoma","volume":"20","author":"Goyal","year":"2015","journal-title":"Oncologist"},{"key":"10.1016\/j.prp.2020.152857_bib0165","first-page":"1333","article-title":"Surgery for periductal infiltrating type intrahepatic cholangiocarcinoma without hilar invasion provides a better outcome than for mass-forming type intrahepatic cholangiocarcinoma without hilar invasion","volume":"57","author":"Imai","year":"2010","journal-title":"Hepatogastroenterology"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033819322794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033819322794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:41:25Z","timestamp":1759732885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033819322794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0344033819322794"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2020.152857","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"C-MET in intrahepatic cholangiocarcinoma: High-Frequency amplification predicts protein expression and a unique molecular subtype","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2020.152857","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152857"}}